Cellebrite Di Ltd (CLBT) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Cellebrite Di Ltd (CLBT) following the 2026 Q2 hedge fund 13F filings?

As of today, CLBT has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLK sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), CLBT gained -23.7% vs -0.3% for XLK. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Cellebrite Di Ltd (CLBT)

222 + Investors. Track Smart Money conviction in CLBT. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — CLBT

Based on 224 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q

For 2 consecutive quarters, more hedge funds added CLBT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

224 hedge funds hold CLBT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +14% more funds vs a year ago

fund count last 6Q

+28 new funds entered over the past year (+14% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟢

More buyers than sellers — 60% buying

142 buying93 selling

Last quarter: 142 funds were net buyers (51 opened a brand new position + 91 added to an existing one). Only 93 were sellers (58 trimmed + 35 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+14 vs last Q)

new funds entering per quarter

Funds opening a new CLBT position: 41 → 46 → 37 → 51. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

📌

Mixed — 33% long-term, 36% new

■ 33% conviction (2yr+) ■ 31% medium ■ 36% new

Of the 224 current holders: 74 (33%) held >2 years, 70 held 1–2 years, and 80 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

💎

Buying through price weakness — shares +4%, value -23%

Value

-22%

+3%

Last quarter: funds added +4% more shares while total portfolio value only changed -23%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

➡️

Steady discovery — ~51 new funds/quarter

47 → 41 → 46 → 37 → 51 new funds/Q

New funds entering each quarter: 41 → 46 → 37 → 51. Consistent flow of new institutional buyers without clear acceleration or slowdown.

📊

Mixed cohorts — 33% veterans, 43% new entrants

■ 33% veterans ■ 24% 1-2yr ■ 43% new

Of 233 current holders: 78 (33%) held 2+ years, 55 held 1–2 years, 100 (43%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

✅

Strong quality — 27% AUM from major funds

27% from top-100 AUM funds

43 of 220 holders rank in the top 100 by AUM, accounting for 27% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

4.1

out of 10

Moderate Exit Risk

Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	222	207	7.25%
13F Shares	127M	123M	3.68%
Total Value	$1.64B	$2.12B	-22.74%
New Positions	50	37	+13
Increased Positions	88	76	+12
Closed Positions	35	24	+11
Reduced Positions	54	64	-10
Total Calls	8	6	33.33%
Total Puts	4	6	-33.33%
PUT/CALL Ratio	0.5	1.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

222

207

7.25%

13F Shares

127M

123M

3.68%

Total Value

$1.64B

$2.12B

-22.74%

New Positions

+13

Increased Positions

+12

Closed Positions

+11

Reduced Positions

-10

Total Calls

33.33%

Total Puts

-33.33%

PUT/CALL Ratio

0.5

1.0

Bullish

Institutional Holders (2026 Q2)

222 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CLBT. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 CLBT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Axon Enterprise, INC.	100.00%	1,310,013	$19.1M
2	True Wind Capital Management, L.P.	89.61%	13,861,007	$202.4M
3	Nine Ten Capital Management LLC	18.75%	4,126,808	$60.3M
4	Greenhaven Road Investment Management, L.P.	11.94%	1,260,039	$18.4M
5	Praesidium Investment Management Company, LLC	10.17%	1,494,438	$21.8M
6	Voss Capital, LP	7.76%	11,441,874	$167.1M
7	Pertento Partners LLP	6.30%	8,004,867	$116.9M
8	Evolutionary Tree Capital Management, LLC	4.19%	152,051	$2.2M
9	Brown Capital Management LLC	3.33%	1,140,261	$16.6M
10	Congruence Capital, LLC	3.07%	805,846	$11.8M
11	Light Street Capital Management, LLC	2.12%	1,312,755	$19.2M
12	Apis Capital Advisors, LLC	2.09%	1,470,000	$21.5M
13	Robertson Opportunity Capital, LLC	2.06%	363,103	$5.3M
14	Roubaix Capital, LLC	2.01%	383,672	$5.6M
15	Progeny 3, Inc.	1.51%	2,000,000	$29.2M
16	Central Securities Corp	1.42%	1,300,000	$19.0M
17	Sphera Management Technology Funds Ltd	1.08%	211,800	$3.1M
18	Portolan Capital Management, LLC	1.06%	1,932,514	$28.2M
19	Walter Public Investments Inc.	0.96%	273,359	$4.0M
20	Granahan Investment Management, LLC	0.86%	1,661,163	$24.3M
21	Redmond Asset Management, LLC	0.73%	200,203	$2.9M
22	Phoenix Financial Ltd.	0.62%	6,181,269	$90.2M
23	ArrowMark Colorado Holdings LLC	0.33%	538,040	$7.9M
24	Rock Creek Group LLC	0.29%	200,000	$2.9M
25	Mirova	0.28%	516,000	$7.5M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Cellebrite Di Ltd (CLBT)

What does the Smart Money Trend signal show for CLBT?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added CLBT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CLBT?

More buyers than sellers — 60% buying: Last quarter: 142 funds were net buyers (51 opened a brand new position + 91 added to an existing one). Only 93 were sellers (58 trimmed + 35 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for CLBT holders?

Strong quality — 27% AUM from major funds: 43 of 220 holders rank in the top 100 by AUM, accounting for 27% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held CLBT?

Mixed — 33% long-term, 36% new: Of the 224 current holders: 74 (33%) held >2 years, 70 held 1–2 years, and 80 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Cellebrite Di Ltd (CLBT) following the 2026 Q2 hedge fund 13F filings?

As of today, CLBT has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLK sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), CLBT has gained -23.7% vs -0.3% for XLK. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Cellebrite Di Ltd (CLBT)

Smart Money Signals — CLBT

Buying streak — 2 quarters in a row

At the ownership peak (100% of max)

Steady growth — +14% more funds vs a year ago

More buyers than sellers — 60% buying

More new buyers each quarter (+14 vs last Q)

Mixed — 33% long-term, 36% new

Buying through price weakness — shares +4%, value -23%

Steady discovery — ~51 new funds/quarter

Mixed cohorts — 33% veterans, 43% new entrants

Strong quality — 27% AUM from major funds

Institutional Sentiment Summary — CLBT

Hedge Fund Ownership: CLBT

Market Analysis: CLBT

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: CLBT

Is It Too Late to Buy Cellebrite Di Ltd (CLBT) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: CLBT

Statistics: CLBT

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Cellebrite Di Ltd (CLBT)

Welcome to 13Foresight!